1 Lebwohl M,Abel E,Zanolli M.Topicalt herapy for psoriasis.Int J Dermatol,1995,34:673.
2 Lebwohl M.Future psoriasis therapy.Dermatol Clin,1995,13:915.
3 Christophers E,Mrowietz U.The inflammatory infiltrate in psoriasis.Clin Dermatol,1995,13:131.
4 Schroder JM.Inf lammatory mediators and chemoattractants.Clin Dermatol,1995,13:137.
5 Kadunce DP,Krueger G G.Pathogenesis of psoriasis:current concepts.Dermatol Clin,1995,13:723.
6 Ruissen VF,Kerkhof PV,Schalkwijk J.Signal transduction pathways in epidermal proliferation and cutaneous inflammation.Clin Dermatol,1995,13:161.
7 Sunderg JP,Robert W,Dunst and DR.Full-t hickness skin grafts from flaky skin mice to nude mice.J Invest Dermatol,1990,95(S):62.
8 Shao CG,Ye GY,Hu CF,et al.Psoriatic research in China.Int J Dermatol,1992,3:840.
9 Barber N.What constitutes good prescribing? Br Med J,1995,310:923.
10 邵长庚.我国银屑病的流行和防治现状.中华皮肤科杂志,1996,29(2):75.
11 刘承煌.银屑病的临床和研究.上海科研技术文献出版社,1994.238.
12 Kaplan A,Matsue H,Shibaki A.The effects of cyclosporin A and FK506 on proliferation and IL-8p roduction of cultured human keratinocytes.J Dermatol Sci,1995,10:130.
13 Borel JF.Mechanism of action and rationale for cyclosporin A in psorias is.Br J Dermatol,1990,122(Suppl 36):5.
14 Steigleder GK,Mahrle G,Schulze HJ.Topical cyclosporin A in psoriasis.Br J Dermatol,1990,122,113.
15 Koo J,Lee J.Cyclosporine what clinicians need to know.Dermatol Clin,1995,13:897.
16 刘昌孝.药代动力学数据库(临床部分).中国医药科技出版社,1994.456.
17 王贤才主译.临床药物大典.山东:青岛出版社,1994.1458. |
